191 related articles for article (PubMed ID: 30107729)
1. Thrombin-Responsive, Brain-Targeting Nanoparticles for Improved Stroke Therapy.
Guo X; Deng G; Liu J; Zou P; Du F; Liu F; Chen AT; Hu R; Li M; Zhang S; Tang Z; Han L; Liu J; Sheth KN; Chen Q; Gou X; Zhou J
ACS Nano; 2018 Aug; 12(8):8723-8732. PubMed ID: 30107729
[TBL] [Abstract][Full Text] [Related]
2. Brain Targeting, Antioxidant Polymeric Nanoparticles for Stroke Drug Delivery and Therapy.
Wu H; Peng B; Mohammed FS; Gao X; Qin Z; Sheth KN; Zhou J; Jiang Z
Small; 2022 Jun; 18(22):e2107126. PubMed ID: 35306743
[TBL] [Abstract][Full Text] [Related]
3. Anti-edema and antioxidant combination therapy for ischemic stroke via glyburide-loaded betulinic acid nanoparticles.
Deng G; Ma C; Zhao H; Zhang S; Liu J; Liu F; Chen Z; Chen AT; Yang X; Avery J; Zou P; Du F; Lim KP; Holden D; Li S; Carson RE; Huang Y; Chen Q; Kimberly WT; Simard JM; Sheth KN; Zhou J
Theranostics; 2019; 9(23):6991-7002. PubMed ID: 31660082
[TBL] [Abstract][Full Text] [Related]
4. Targeted drug delivery to ischemic stroke via chlorotoxin-anchored, lexiscan-loaded nanoparticles.
Han L; Cai Q; Tian D; Kong DK; Gou X; Chen Z; Strittmatter SM; Wang Z; Sheth KN; Zhou J
Nanomedicine; 2016 Oct; 12(7):1833-1842. PubMed ID: 27039220
[TBL] [Abstract][Full Text] [Related]
5. Targeted Drug Delivery to Stroke via Chemotactic Recruitment of Nanoparticles Coated with Membrane of Engineered Neural Stem Cells.
Ma J; Zhang S; Liu J; Liu F; Du F; Li M; Chen AT; Bao Y; Suh HW; Avery J; Deng G; Zhou Y; Wu P; Sheth K; Wang H; Zhou J
Small; 2019 Aug; 15(35):e1902011. PubMed ID: 31290245
[TBL] [Abstract][Full Text] [Related]
6. Bioengineered Boronic Ester Modified Dextran Polymer Nanoparticles as Reactive Oxygen Species Responsive Nanocarrier for Ischemic Stroke Treatment.
Lv W; Xu J; Wang X; Li X; Xu Q; Xin H
ACS Nano; 2018 Jun; 12(6):5417-5426. PubMed ID: 29869497
[TBL] [Abstract][Full Text] [Related]
7. Apixaban decreases brain thrombin activity in a male mouse model of acute ischemic stroke.
Bushi D; Chapman J; Wohl A; Stein ES; Feingold E; Tanne D
J Neurosci Res; 2018 Aug; 96(8):1406-1411. PubMed ID: 29761540
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Outcomes in Patients Aged ≤70 Years With Intravenous Glyburide From the Phase II GAMES-RP Study of Large Hemispheric Infarction: An Exploratory Analysis.
Sheth KN; Petersen NH; Cheung K; Elm JJ; Hinson HE; Molyneaux BJ; Beslow LA; Sze GK; Simard JM; Kimberly WT
Stroke; 2018 Jun; 49(6):1457-1463. PubMed ID: 29789393
[TBL] [Abstract][Full Text] [Related]
9. Advances in nanomedicines: a promising therapeutic strategy for ischemic cerebral stroke treatment.
Li J; Xie F; Ma X
Nanomedicine (Lond); 2024 Apr; 19(9):811-835. PubMed ID: 38445614
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticles-mediated emerging approaches for effective treatment of ischemic stroke.
He W; Zhang Z; Sha X
Biomaterials; 2021 Oct; 277():121111. PubMed ID: 34488117
[TBL] [Abstract][Full Text] [Related]
11. pH-Sensitive, Cerebral Vasculature-Targeting Hydroxyethyl Starch Functionalized Nanoparticles for Improved Angiogenesis and Neurological Function Recovery in Ischemic Stroke.
Yang H; Luo Y; Hu H; Yang S; Li Y; Jin H; Chen S; He Q; Hong C; Wu J; Wan Y; Li M; Li Z; Yang X; Su Y; Zhou Y; Hu B
Adv Healthc Mater; 2021 Jun; 10(12):e2100028. PubMed ID: 34028998
[TBL] [Abstract][Full Text] [Related]
12. Increased thrombin activity following reperfusion after ischemic stroke alters synaptic transmission in the hippocampus.
Bushi D; Ben Shimon M; Shavit Stein E; Chapman J; Maggio N; Tanne D
J Neurochem; 2015 Dec; 135(6):1140-8. PubMed ID: 26390857
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide donor upregulation of stromal cell-derived factor-1/chemokine (CXC motif) receptor 4 enhances bone marrow stromal cell migration into ischemic brain after stroke.
Cui X; Chen J; Zacharek A; Li Y; Roberts C; Kapke A; Savant-Bhonsale S; Chopp M
Stem Cells; 2007 Nov; 25(11):2777-85. PubMed ID: 17641243
[TBL] [Abstract][Full Text] [Related]
14. Brain-targeting, acid-responsive antioxidant nanoparticles for stroke treatment and drug delivery.
Zhang S; Peng B; Chen Z; Yu J; Deng G; Bao Y; Ma C; Du F; Sheu WC; Kimberly WT; Simard JM; Coman D; Chen Q; Hyder F; Zhou J; Sheth KN
Bioact Mater; 2022 Oct; 16():57-65. PubMed ID: 35386312
[TBL] [Abstract][Full Text] [Related]
15. The application of nanoparticles for neuroprotection in acute ischemic stroke.
Chen L; Gao X
Ther Deliv; 2017 Oct; 8(10):915-928. PubMed ID: 28944741
[TBL] [Abstract][Full Text] [Related]
16. Direct Macromolecular Drug Delivery to Cerebral Ischemia Area using Neutrophil-Mediated Nanoparticles.
Zhang C; Ling CL; Pang L; Wang Q; Liu JX; Wang BS; Liang JM; Guo YZ; Qin J; Wang JX
Theranostics; 2017; 7(13):3260-3275. PubMed ID: 28900508
[TBL] [Abstract][Full Text] [Related]
17. Salvaging brain ischemia by increasing neuroprotectant uptake via nanoagonist mediated blood brain barrier permeability enhancement.
Zheng S; Bai YY; Liu Y; Gao X; Li Y; Changyi Y; Wang Y; Chang D; Ju S; Li C
Biomaterials; 2015 Oct; 66():9-20. PubMed ID: 26188608
[TBL] [Abstract][Full Text] [Related]
18. Brain Drug Delivery Systems for the Stroke Intervention and Recovery.
Luo T; Wang J; Hao S; Guo T; Ren P; Cheng Z; Gao F; Gong Y; Wang B
Curr Pharm Des; 2017; 23(15):2258-2267. PubMed ID: 27784243
[TBL] [Abstract][Full Text] [Related]
19. Improved oral bioavailability of glyburide by a self-nanoemulsifying drug delivery system.
Liu H; Shang K; Liu W; Leng D; Li R; Kong Y; Zhang T
J Microencapsul; 2014; 31(3):277-83. PubMed ID: 24533514
[TBL] [Abstract][Full Text] [Related]
20. Human Data Supporting Glyburide in Ischemic Stroke.
Sheth KN; Simard JM; Elm J; Kronenberg G; Kunte H; Kimberly WT
Acta Neurochir Suppl; 2016; 121():13-8. PubMed ID: 26463916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
